Eishi Baba

5.7k total citations
194 papers, 3.1k citations indexed

About

Eishi Baba is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Eishi Baba has authored 194 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Oncology, 58 papers in Pulmonary and Respiratory Medicine and 37 papers in Immunology. Recurrent topics in Eishi Baba's work include Colorectal Cancer Treatments and Studies (40 papers), Gastric Cancer Management and Outcomes (28 papers) and Cancer Treatment and Pharmacology (24 papers). Eishi Baba is often cited by papers focused on Colorectal Cancer Treatments and Studies (40 papers), Gastric Cancer Management and Outcomes (28 papers) and Cancer Treatment and Pharmacology (24 papers). Eishi Baba collaborates with scholars based in Japan, United States and Taiwan. Eishi Baba's co-authors include Hitoshi Kusaba, Hiroshi Ariyama, Tsuneo FUKATA, Koichi Akashi, Akira Arakawa, Kazumi Sasai, Mine Harada, Shuji Nakano, Kenji Mitsugi and Taito Esaki and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Eishi Baba

182 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eishi Baba Japan	33	1.2k	935	806	626	343	194	3.1k
Aldo Venuti Italy	35	824 0.7×	802 0.9×	1.2k 1.5×	367 0.6×	477 1.4×	137	3.8k
Norimitsu Kadowaki Japan	34	1.5k 1.2×	6.7k 7.1×	1.3k 1.6×	467 0.7×	257 0.7×	170	9.0k
Scott A. Hammond United States	34	1.7k 1.4×	2.1k 2.2×	753 0.9×	287 0.5×	96 0.3×	82	3.8k
Stanleyson V. Hato Netherlands	23	1.0k 0.9×	1.2k 1.3×	711 0.9×	223 0.4×	152 0.4×	29	2.7k
Yukari Eizuru Japan	29	1.4k 1.1×	471 0.5×	382 0.5×	439 0.7×	670 2.0×	142	2.8k
Finlay W. McNab United Kingdom	14	595 0.5×	2.7k 2.9×	879 1.1×	100 0.2×	389 1.1×	16	4.3k
Nicola La Monica Italy	41	665 0.5×	1.4k 1.5×	2.3k 2.9×	206 0.3×	128 0.4×	103	5.6k
Ih‐Jen Su Taiwan	42	1.0k 0.8×	563 0.6×	1.2k 1.4×	121 0.2×	350 1.0×	105	5.1k
Kenji Tani Japan	29	520 0.4×	1.6k 1.7×	918 1.1×	588 0.9×	224 0.7×	174	3.6k
Hidemi Takahashi Japan	34	649 0.5×	2.7k 2.9×	973 1.2×	110 0.2×	316 0.9×	138	4.3k

Countries citing papers authored by Eishi Baba

Since Specialization

Citations

This map shows the geographic impact of Eishi Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eishi Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eishi Baba more than expected).

Fields of papers citing papers by Eishi Baba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eishi Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eishi Baba. The network helps show where Eishi Baba may publish in the future.

Co-authorship network of co-authors of Eishi Baba

This figure shows the co-authorship network connecting the top 25 collaborators of Eishi Baba. A scholar is included among the top collaborators of Eishi Baba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eishi Baba. Eishi Baba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Isobe, Taichi, Hirofumi Ohmura, Toshihiro Yamaguchi, et al.. (2025). Metastatic urachal carcinoma treated with trifluridine/tipiracil and bevacizumab: a case report. International Cancer Conference Journal. 14(3). 280–288.

Yamaguchi, Toshihiro, Kenji Tsuchihashi, Sayaka Ueno, et al.. (2025). Efficacy of pembrolizumab in microsatellite-stable, tumor mutational burden-high metastatic colorectal cancer: genomic signatures and clinical outcomes. ESMO Open. 10(1). 104108–104108. 3 indexed citations

Yamaguchi, Toshihiro, Mamoru Ito, Taichi Isobe, et al.. (2024). Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2–Positive Advanced Gastric Cancer. JCO Precision Oncology. 8(8). e2300681–e2300681. 2 indexed citations

Matsumura, Takashi, Kenji Tsuchihashi, Takeo Yamamoto, et al.. (2024). Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab. Internal Medicine. 64(11). 1728–1732. 2 indexed citations

Ito, Mamoru, Michitaka Nakano, Hiroshi Ariyama, et al.. (2022). Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusions. Cancer Letters. 532. 215597–215597. 13 indexed citations

Tsuchihashi, Kenji, Yuki Hirata, Juntaro Yamasaki, et al.. (2022). Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer. Biochemistry and Biophysics Reports. 30. 101246–101246. 1 indexed citations

Nishikawa, Kazuo, Shuichi Hironaka, Takashi Inagaki, et al.. (2022). A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site. Japanese Journal of Clinical Oncology. 52(12). 1416–1422. 2 indexed citations

Hieda, Michinari, Taku Yokoyama, Mitsuhiro Fukata, et al.. (2022). Effect of renin–angiotensin system inhibitors in patients with cancer treated with anti-VEGF therapy. Open Heart. 9(2). e002135–e002135. 3 indexed citations

Shitara, Kohei, Eishi Baba, Kazumasa Fujitani, et al.. (2021). Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancer. Gastric Cancer. 24(4). 780–789. 42 indexed citations

10.

Tsuchihashi, Kenji, Hirofumi Ohmura, Toshihiro Yamaguchi, et al.. (2020). RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells. Biochemical and Biophysical Research Communications. 530(1). 235–239. 69 indexed citations

11.

Shirakawa, Tsuyoshi, Kojiro Hata, Kimitaka Suetsugu, et al.. (2017). Analysis of a Questionnaire Survey regarding Current Conditions against Exposure to Anticancer Drugs and Reports of Cancer Chemotherapy at Outpatient Departments in Japan. Pharmacology & Pharmacy. 8(5). 140–152.

12.

Tsuchihashi, Kenji, Keita Uchino, Tsuyoshi Shirakawa, et al.. (2012). Systemic chemotherapy for metastatic non-mucinous appendiceal adenocarcinoma: a case report and literature review. International Cancer Conference Journal. 2(1). 36–40.

13.

Yamaguchi, Kensei, Akira Sawaki, Toshihiko Doi, et al.. (2012). Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study. Gastric Cancer. 16(2). 175–182. 20 indexed citations

14.

Abe, Yasunobu, Tetsuhide Ito, Eishi Baba, et al.. (2010). Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer. Suizo. 25(1). 92–94.

15.

Tabrizi, Sarah J., Hiroaki Niiro, Goichi Yoshimoto, et al.. (2009). T Cell Leukemia/Lymphoma 1 and Galectin-1 Regulate Survival/Cell Death Pathways in Human Naive and IgM+ Memory B Cells through Altering Balances in Bcl-2 Family Proteins. The Journal of Immunology. 182(3). 1490–1499. 40 indexed citations

16.

Oda, Tsukasa, Eishi Baba, Masaru Harada, et al.. (2008). MEFV mutation analysis of familial Mediterranean fever in Japan.. PubMed. 26(1). 13–7. 42 indexed citations

17.

Onishi, Hideya, Takashi Morisaki, Kotaro Matsumoto, et al.. (2005). Evaluation of a dysfunctional and short-lived subset of monocyte-derived dendritic cells from cancer patients.. PubMed. 25(5). 3445–51. 4 indexed citations

18.

Kato, Ken, Kenji Mitsugi, Minoru Nakamura, et al.. (2005). Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 57(1). 114–119. 3 indexed citations

19.

Kubo, Makoto, Takashi Morisaki, Akira Tasaki, et al.. (2004). Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer.. PubMed. 23(6a). 4443–9. 25 indexed citations

20.

Baba, Eishi, Yoshiaki Takahashi, Reiko Tanaka, et al.. (2001). Functional CD4 T Cells after Intercellular Molecular Transfer of OX40 Ligand. The Journal of Immunology. 167(2). 875–883. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact